Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hamaoka

Showing results (141-150 of 413) with videos related to

Pageof 42
Sort By:
The Journal of Experimental Medicine|May 1, 1996
Protection from anti-TCR/CD3-induced apoptosis in immature thymocytes by a signal through thymic shared antigen-1/stem cell antigen-2S Noda, A Kosugi, S Saitoh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1989
Cytotoxic T lymphocyte unresponsiveness induced by prolonged treatment with immobilized anti-CD3 antibody. Association of impairment of cytolytic activity with temporary depletion of intracellular protein kinase CS Sano, C Kiyotaki, Y Tatsumi, et al.
European Journal of Immunology|December 1, 1989
Disparate functions of I-A and I-E molecules on B cells as evidenced by the inhibition with anti-I-A and anti-I-E antibodies of polyclonal B cell activationY Takahama, S Ono, K Ishihara, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Studies on the recovery from tolerance to tumor antigens. I. Bone marrow cells from tolerant hosts are not rendered tolerant, but provide potential to reconstitute tumor-specific effector T cell clonesH Fujiwara, S Sato, A Kosugi, et al.
Immunity|June 23, 2001
Involvement of SHP-1 tyrosine phosphatase in TCR-mediated signaling pathways in lipid raftsA Kosugi, J Sakakura, K Yasuda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1986
Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. II. Evidence for interaction of B151-TRF2 with glycoprotein on B cell membrane via recognition of terminal N-acetyl-D-glucosamine residue(s)Y Katoh, S Ono, Y Takahama, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1988
Separation of the tumor rejection antigen of Rous sarcoma virus-induced murine fibrosarcomaT Suda, J Shimizu, Y Mizushima, et al.
Gan|August 1, 1976
Isolation of soluble immunosuppressive substance(s) from Ehrlich ascites tumor cell nucleiS Haba, T Hamaoka, H Masaki, et al.
International Journal of Sports Medicine|May 12, 2015
Planned Overreaching and Subsequent Short-term Detraining Enhance Cycle Sprint PerformanceY Hasegawa, T Ijichi, Y Kurosawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1982
Acceptor site(s) for T cell-replacing factor (TRF) on B lymphocytes. I. TRF-substituting activity of anti-TRF acceptor site(s) antibody in the triggering of B cellsK Takatsu, Y Sano, N Hashimoto, et al.
Pageof 42

Showing results (141-150 of 413) with videos related to

Sort By:
Pageof 42
The Journal of Experimental Medicine|May 1, 1996
Protection from anti-TCR/CD3-induced apoptosis in immature thymocytes by a signal through thymic shared antigen-1/stem cell antigen-2S Noda, A Kosugi, S Saitoh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1989
Cytotoxic T lymphocyte unresponsiveness induced by prolonged treatment with immobilized anti-CD3 antibody. Association of impairment of cytolytic activity with temporary depletion of intracellular protein kinase CS Sano, C Kiyotaki, Y Tatsumi, et al.
European Journal of Immunology|December 1, 1989
Disparate functions of I-A and I-E molecules on B cells as evidenced by the inhibition with anti-I-A and anti-I-E antibodies of polyclonal B cell activationY Takahama, S Ono, K Ishihara, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Studies on the recovery from tolerance to tumor antigens. I. Bone marrow cells from tolerant hosts are not rendered tolerant, but provide potential to reconstitute tumor-specific effector T cell clonesH Fujiwara, S Sato, A Kosugi, et al.
Immunity|June 23, 2001
Involvement of SHP-1 tyrosine phosphatase in TCR-mediated signaling pathways in lipid raftsA Kosugi, J Sakakura, K Yasuda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1986
Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. II. Evidence for interaction of B151-TRF2 with glycoprotein on B cell membrane via recognition of terminal N-acetyl-D-glucosamine residue(s)Y Katoh, S Ono, Y Takahama, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1988
Separation of the tumor rejection antigen of Rous sarcoma virus-induced murine fibrosarcomaT Suda, J Shimizu, Y Mizushima, et al.
Gan|August 1, 1976
Isolation of soluble immunosuppressive substance(s) from Ehrlich ascites tumor cell nucleiS Haba, T Hamaoka, H Masaki, et al.
International Journal of Sports Medicine|May 12, 2015
Planned Overreaching and Subsequent Short-term Detraining Enhance Cycle Sprint PerformanceY Hasegawa, T Ijichi, Y Kurosawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1982
Acceptor site(s) for T cell-replacing factor (TRF) on B lymphocytes. I. TRF-substituting activity of anti-TRF acceptor site(s) antibody in the triggering of B cellsK Takatsu, Y Sano, N Hashimoto, et al.
Pageof 42